Eduardo Vivas - Jun 5, 2024 Form 4 Insider Report for AppLovin Corp (APP)

Role
Director
Signature
/s/ Victoria Valenzuela, Attorney-in-fact
Stock symbol
APP
Transactions as of
Jun 5, 2024
Transactions value $
$0
Form type
4
Date filed
6/6/2024, 07:01 PM
Previous filing
May 2, 2024
Next filing
Jun 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APP Class A Common Stock Award $0 +2.99K +0.04% $0.00 8.36M Jun 5, 2024 Direct F1, F2
holding APP Class A Common Stock 142K Jun 5, 2024 See footnote F3
holding APP Class A Common Stock 123K Jun 5, 2024 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. 100% of the RSUs shall vest on the earlier of (i) the one-year anniversary of the date the Annual Award is granted or (ii) the day prior to the date of the Annual Meeting next following the date the Annual Award is granted, subject to the Outside Director continuing to be a Service Provider through the applicable vesting date.
F2 Certain of these securities are represented by RSUs.
F3 Shares are held by Vivas Family Trust U/A/D 10/26/2020 for the benefit of members of Reporting Person's immediate family. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4 Shares are held by Arutyunyan Family Trust U/A/D 12/1/20 for the benefit of members of Reporting Person's immediate family. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.